Back to search

Article

Characterization of an EG.5.1 clinical isolate <i>in vitro</i> and <i>in vivo</i>

2023-09-01

Abstract excerpt

EG.5.1 is a subvariant of the SARS-CoV-2 Omicron XBB variant that is rapidly increasing in prevalence worldwide. EG.5.1 has additional substitutions in its spike protein (namely, Q52H and F456L) compared with XBB.1.5. However, the pathogenicity, transmissibility, and immune evasion properties of clinical isolates of EG.5.1 are largely unknown. In this study, we used wild-type Syrian hamsters to investigate the rep...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d422acd4-ceb8-589a-bfa5-f9cb6ddb14b0
DOI
10.1101/2023.08.31.555819
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Characterization of an EG.5.1 clinical isolate <i>in vitro</i> and <i>in vivo</i>DOI 10.1101/2023.08.31.555819
Select a neighboring publication to make it the new centre.